Miikka Vikkula

Professor at de Duve Institute

Miikka Vikkula serves as Vice President of the International Society for the Study of Vascular Anomalies since June 2024. Vikkula also holds the position of European Coordinator for the Revamp Project at Fondation Leducq and is an investigator at the WEL Research Institute. In addition, Vikkula chairs the VASCA working group within VASCERN, the European Reference Network on Rare Multisystemic Vascular Diseases, and has been a full member of the Académie royale de Médecine de Belgique since June 2016. As a faculty member and Laboratory Director at the de Duve Institute since February 1997, Vikkula has played a pivotal role in various research initiatives, including serving as coordinator for the European ITN network VACure from March 2019 to April 2024. Vikkula's extensive education includes a Doctor of Medicine from the University of Helsinki and multiple advanced degrees in Molecular Genetics from Harvard Medical School and Université catholique de Louvain.

Location

Brussels, Belgium

Links


Org chart


Teams

This person is not in any teams


Offices


de Duve Institute

Founded by Nobel laureate Christian de Duve, the de Duve Institute is a multidisciplinary biomedical research institute bringing together more than 250 researchers and technicians from close to 40 countries on the UCLouvain campus in Brussels, who strive to better understand diseases in order to better cure them. To achieve this goal, research at the Institute is based on three principles: priority to basic research and to the freedom of the investigators, focus on medical benefits resulting from basic discoveries, special attention to collaborative and interdisciplinary research. Current research at the de Duve Institute is covering many areas of basic biomedical research, with the aim to improve the diagnosis and treatment of: - Cancers, leukemias and lymphomas, and their treatment with immunotherapy; - Acquired (diabetes) and hereditary (rare diseases) metabolic diseases; - Diseases related to immunity disorders (asthma, multiple sclerosis, systemic scleroderma, Crohn's disease, psoriasis); - Viral and bacterial infections, with a major research focus on the development of new antibiotics and new ways to fight bacteria; - Developmental disorders of vascular (angioma, lymphedema) and skeletal (cleft lip) systems. To keep abreast of our current events and discoveries, follow us on: https://www.facebook.com/deDuveInstitute/ https://www.youtube.com/channel/UCUtTsc5mO6rZaEP7ZFLcXrQ https://twitter.com/deDuveInstitute https://www.instagram.com/deduveinstitute1974/


Headquarters

Brussels, Belgium

Employees

201-500

Links